Xiaohong

Xiaohong Ma has been working in the field of CAR T-cell therapy for acute myeloid leukemia and multiple solid cancers since 2001. With experience in generating and expanding CAR-T cells, as well as conducting function assays in vitro, Xiaohong Ma has also assessed CAR-T cell anti-tumor effects in animal tumor models. Additionally, Xiaohong Ma has experience in preclinical programs in Ophthalmology and Neuropathic pain, focusing on viral and non-viral vector transductions and transfections in primary and transformed cell lines. With a Bachelor in Medical Science from Anhui Medical University, Xiaohong Ma brings a strong educational background to their work in biomedical research.